Harmony Biosciences Holdings, Inc.
HRMY
$38.12
-$0.38-0.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 261.28M | 215.39M | 243.78M | 239.46M | 200.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 261.28M | 215.39M | 243.78M | 239.46M | 200.49M |
| Cost of Revenue | 63.20M | 44.51M | 68.55M | 59.65M | 38.15M |
| Gross Profit | 198.08M | 170.88M | 175.23M | 179.81M | 162.34M |
| SG&A Expenses | 62.17M | 64.20M | 86.74M | 59.36M | 64.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 171.96M | 178.10M | 205.22M | 173.97M | 152.31M |
| Operating Income | 89.32M | 37.29M | 38.56M | 65.49M | 48.18M |
| Income Before Tax | 93.27M | 39.69M | 40.76M | 67.49M | 49.64M |
| Income Tax Expenses | 17.83M | 7.20M | 18.27M | 16.63M | 9.86M |
| Earnings from Continuing Operations | 75.43M | 32.49M | 22.49M | 50.87M | 39.78M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 75.43M | 32.49M | 22.49M | 50.87M | 39.78M |
| EBIT | 89.32M | 37.29M | 38.56M | 65.49M | 48.18M |
| EBITDA | 95.28M | 43.26M | 45.99M | 71.46M | 54.15M |
| EPS Basic | 1.30 | 0.56 | 0.39 | 0.88 | 0.69 |
| Normalized Basic EPS | 1.01 | 0.43 | 0.44 | 0.73 | 0.54 |
| EPS Diluted | 1.28 | 0.55 | 0.38 | 0.87 | 0.68 |
| Normalized Diluted EPS | 0.99 | 0.42 | 0.43 | 0.72 | 0.53 |
| Average Basic Shares Outstanding | 57.93M | 57.82M | 57.63M | 57.55M | 57.47M |
| Average Diluted Shares Outstanding | 58.76M | 58.78M | 58.70M | 58.72M | 58.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |